M&A Deal Summary

MJH Life Sciences Acquires Revolutionizing Atopic Dermatitis

On November 18, 2024, MJH Life Sciences acquired business services company Revolutionizing Atopic Dermatitis

Acquisition Highlights
  • This is MJH Life Sciences’ 2nd transaction in the Business Services sector.
  • This is MJH Life Sciences’ 7th transaction in the United States.
  • This is MJH Life Sciences’ 1st transaction in Illinois.

M&A Deal Summary

Date 2024-11-18
Target Revolutionizing Atopic Dermatitis
Sector Business Services
Buyer(s) MJH Life Sciences
Deal Type Add-on Acquisition

Target

Revolutionizing Atopic Dermatitis

Chicago, Illinois, United States
Revolutionizing Atopic Dermatitis is a CME-certified conference renowned for advancing knowledge in dermatology through the discussion of cutting-edge research. Revolutionizing Atopic Dermatitis is based in Chicago, Illinois.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

MJH Life Sciences

Cranbury, New Jersey, United States

Category Company
Sector Media
DESCRIPTION

MJH Life Sciences is an independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels, providing health care professionals with the information and resources they need to optimize patient outcomes. MJH Life Sciences is based in Cranbury, New Jersey.


DEAL STATS #
Overall 7 of 7
Sector (Business Services) 2 of 2
Type (Add-on Acquisition) 6 of 6
State (Illinois) 1 of 1
Country (United States) 7 of 7
Year (2024) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-10-09 EnVision Summit

Georges Mills, New Hampshire, United States

EnVision Summit is a continuing medical education (CME) conference for ophthalmologists, held annually in Puerto Rico. EnVision Summit is based in Georges Mills, New Hampshire.

Buy -